Medical device recalls Moderate risk

Randox Laboratories, Limited recalls Human Assayed Multi-Sera Level 2, Model NO. HN1530 Product Usage: This product is intended for in vitro diagnostic use,…

Recall date
June 11, 2019
Source
U.S. Food & Drug Administration (FDA) — enforcement report
Recall number
Z-2150-2019
FDA classification
Class II
Brand / firm
Randox Laboratories, Limited
Sold / distributed
US Nationwide Distribution - AZ CA CT FL GA IL KY LA MA MD MI MN MO NJ NY OH OK OR PA TX UT VA WA WI WV and PR. Worldwide foreign distribution.

Why it was recalled

The RX Series control target and range value for ALT (Tris buffer without P5P 37C), Bicarbonate and Gamma-GT has been incorrectly assigned in specific lots of the Human Assayed Multi-Sera Controls.

Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.

What was recalled

Human Assayed Multi-Sera Level 2, Model NO. HN1530 Product Usage: This product is intended for in vitro diagnostic use, in the quality control of diagnostic assays. The Human Assayed Multi-sera is for the control of accuracy.

Get recall alerts

Free email alert whenever Randox Laboratories, Limited has a new recall — straight from official government data. Unsubscribe anytime.

More recalls from: Randox Laboratories, Limited